Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
March 5, 2025
A comparative analysis of select P450 enzymes in uninduced and PB/BNF-induced hamster and rat liver S9
Kristie Evans, Slaydon Boitnotte, Errol Zeiger, et al.
Mutagenesis
|
May 19, 2009
Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity
Markus Kamber, Sini Flückiger-Isler, Günter Engelhardt, et al.
Journal of Agricultural and Food Chemistry
|
July 16, 2008
Inhibition of rat testicular nuclear kinesins (krp2; KIFC5A) by acrylamide as a basis for establishing a genotoxicity threshold
Marvin A Friedman, Errol Zeiger, Dennis E Marroni, et al.
Mutation Research
|
March 31, 2011
Guidance for understanding solubility as a limiting factor for selecting the upper test concentration in the OECD in vitro micronucleus assay test guideline no. 487
Marilyn J Aardema, Sheila Galloway, Errol Zeiger, et al.
Environmental and Molecular Mutagenesis
|
April 23, 2024
Within-laboratory reproducibility of Ames test results: Are repeat tests necessary?
Errol Zeiger, Constance A Mitchell, Stefan Pfuhler, et al.
Environmental Health Perspectives
|
August 3, 2006
The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses. Phase 1: use of a potent agonist and a potent antagonist to test the standardized protocol
William Owens, Errol Zeiger, Michael Walker, et al.
Mutagenesis
|
December 13, 2006
Harmonisation of the micronucleus assay in human buccal cells--a Human Micronucleus (HUMN) project (www.humn.org) initiative commencing in 2007
Michael Fenech, Claudia Bolognesi, Micheline Kirsch-Volders, et al.
Environmental Health Perspectives
|
May 24, 2007
The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies
William Owens, L Earl Gray, Errol Zeiger, et al.
Mutation Research
|
June 3, 2008
The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps
Nina Holland, Claudia Bolognesi, Micheline Kirsch-Volders, et al.
Regulatory Toxicology and Pharmacology : RTP
|
January 2, 2010
An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats"
Ernest E McConnell, Jack Lippes, Roger G Growe, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
March 5, 2025
A comparative analysis of select P450 enzymes in uninduced and PB/BNF-induced hamster and rat liver S9
Kristie Evans, Slaydon Boitnotte, Errol Zeiger, et al.
Mutagenesis
|
May 19, 2009
Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity
Markus Kamber, Sini Flückiger-Isler, Günter Engelhardt, et al.
Journal of Agricultural and Food Chemistry
|
July 16, 2008
Inhibition of rat testicular nuclear kinesins (krp2; KIFC5A) by acrylamide as a basis for establishing a genotoxicity threshold
Marvin A Friedman, Errol Zeiger, Dennis E Marroni, et al.
Mutation Research
|
March 31, 2011
Guidance for understanding solubility as a limiting factor for selecting the upper test concentration in the OECD in vitro micronucleus assay test guideline no. 487
Marilyn J Aardema, Sheila Galloway, Errol Zeiger, et al.
Environmental and Molecular Mutagenesis
|
April 23, 2024
Within-laboratory reproducibility of Ames test results: Are repeat tests necessary?
Errol Zeiger, Constance A Mitchell, Stefan Pfuhler, et al.
Environmental Health Perspectives
|
August 3, 2006
The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses. Phase 1: use of a potent agonist and a potent antagonist to test the standardized protocol
William Owens, Errol Zeiger, Michael Walker, et al.
Mutagenesis
|
December 13, 2006
Harmonisation of the micronucleus assay in human buccal cells--a Human Micronucleus (HUMN) project (www.humn.org) initiative commencing in 2007
Michael Fenech, Claudia Bolognesi, Micheline Kirsch-Volders, et al.
Environmental Health Perspectives
|
May 24, 2007
The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies
William Owens, L Earl Gray, Errol Zeiger, et al.
Mutation Research
|
June 3, 2008
The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps
Nina Holland, Claudia Bolognesi, Micheline Kirsch-Volders, et al.
Regulatory Toxicology and Pharmacology : RTP
|
January 2, 2010
An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats"
Ernest E McConnell, Jack Lippes, Roger G Growe, et al.
Page
of 6